MEA Aesthetic devices market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.3 OVERVIEW OF MIDDLE EAST & AFRICA AESTHETIC DEVICE MARKET 32
1.4 LIMITATIONS 34
1.5 MARKETS COVERED 34
2 MARKET SEGMENTATION 37
2.1 MARKETS COVERED 37
2.2 GEOGRAPHICAL SCOPE 38
2.3 YEARS CONSIDERED FOR THE STUDY 39
2.4 CURRENCY AND PRICING 39
2.5 DBMR TRIPOD DATA VALIDATION MODEL 40
2.6 MULTIVARIATE MODELLING 43
2.7 PRODUCT LIFELINE CURVE 43
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.9 DBMR MARKET POSITION GRID 45
2.10 MARKET APPLICATION COVERAGE GRID 46
2.11 VENDOR SHARE ANALYSIS 47
2.12 SECONDARY SOURCES 48
2.13 ASSUMPTIONS 49
3 EXECUTIVE SUMMARY 50
3.1 PESTEL'S MODEL 54
3.2 PORTER'S FIVE FORCES MODEL 55
4 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET: REGULATIONS 56
4.1 REGULATION OF COSMETIC-RELATED MEDICAL DEVICES 56
5 MARKET OVERVIEW 63
5.1 DRIVERS 65
5.1.1 RISING PREVALENCE OF MINIMALLY INVASIVE PROCEDURES 65
5.1.2 INCREASING GERIATRIC POPULATION 65
5.1.3 TECHNOLOGICAL ADVANCEMENTS IN AESTHETIC DEVICES 66
5.1.4 STRATEGIC INITIATIVES BY MARKET PLAYERS 66
5.2 RESTRAINTS 67
5.2.1 HIGH COST OF AESTHETIC SURGICAL PROCEDURES 67
5.2.2 SIDE EFFECTS RELATED TO AESTHETIC ENERGY BASED DEVICES 67

5.3 OPPORTUNITIES 68
5.3.1 INCREASING HEALTHCARE EXPENDITURE 68
5.3.2 INCREASING FUNDING ACTIVITIES FOR AESTHETIC RESEARCH 69
5.3.3 INCREASING AWARENESS TOWARDS AESTHETIC SURGERIES 69
5.3.4 INCREASING RESEARCH AND DEVELOPMENT 70
5.4 CHALLENGES 70
5.4.1 LACK OF SKILLED PROFESSIONALS 70
5.4.2 AVAILABILITY OF ALTERNATIVES 71
6 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET, BY PRODUCTS 72
6.1 OVERVIEW 73
6.2 FACIAL AESTHETICS PRODUCTS 76
6.2.1 BOTULINUM TOXIC 77
6.2.2 DERMAL FILLERS 77
6.2.3 MICRODERMABRASION 77
6.2.4 CHEMICAL PEELS 77
6.3 BODY CONTOURING DEVICES 77
6.3.1 LIPOSUCTION DEVICES 78
6.3.2 CELLULITE REDUCTION DEVICES 78
6.3.3 NON-SURGICAL FAT REDUCTION DEVICES 79
6.4 COSMETIC IMPLANTS 79
6.4.1 BREAST IMPLANTS 80
6.4.2 DENTAL IMPLANTS 80
6.4.3 IMPLANTS FOR THE BODY 80
6.4.4 CUSTOM MADE IMPLANTS 80
6.5 SKIN AESTHETIC DEVICES 80
6.5.1 NON-SURGICAL SKIN TIGHTENING DEVICES 81
6.5.2 LASER RESURFACING DEVICES 82
6.5.3 LIGHT THERAPY DEVICES 82
6.5.4 MICRO-NEEDLING PRODUCTS 82
6.6 HAIR REMOVAL DEVICES 82
6.6.1 LASER HAIR REMOVAL DEVICES 83
6.6.2 IPL HAIR REMOVAL DEVICES 83
6.7 OTHERS 83
6.7.1 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS 84
6.7.2 PHYSICIAN-DISPENSED EYELASH PRODUCTS 84
6.7.3 THREAD LIFT PRODUCTS 84
6.7.4 TATTOO REMOVAL DEVICES 85
6.7.5 NAIL TREATMENT LASER DEVICES 85

7 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET, BY RAW MATERIALS 86
7.1 OVERVIEW 87
7.2 POLYMERS 90
7.3 BIOMATERIALS 90
7.4 METALS 91
8 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET, BY END USER 93
8.1 OVERVIEW 94
8.2 HOSPITALS 97
8.3 DERMATOLOGY CLINICS 98
8.4 CLINICS 99
8.5 ACADEMIC AND PRIVATE RESEARCH INSTITUTES 99
8.6 OTHERS 100
8.6.1 COSMETIC CENTERS 101
8.6.2 HOMECARE 101
8.6.3 MEDICAL SPAS AND BEAUTY CENTERS 101
9 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET, BY DISTRIBUTION CHANNEL 103
9.1 OVERVIEW 104
9.2 DIRECT TENDER 107
9.3 RETAIL SALES 107
10 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET, BY REGION 109
10.1 MIDDLE EAST & AFRICA 110
10.1.1 SOUTH AFRICA 117
10.1.2 SAUDI ARABIA 120
10.1.3 U.A.E. 123
10.1.4 EGYPT 126
10.1.5 ISRAEL 129
10.1.6 REST OF MIDDLE EAST & AFRICA 132
11 MIDDLE EAST & AFRICA AESTHETIC DEVICES MARKET: COMPANY LANDSCAPE 133
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 133
12 SWOT ANALYSIS 134

13 COMPANY PROFILE 135
13.1 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.) 135
13.1.1 COMPANY SNAPSHOT 135
13.1.2 COMPANY SHARE ANALYSIS 135
13.1.3 PRODUCT PORTFOLIO 136
13.1.4 RECENT DEVELOPMENTS 137
13.2 MENTOR WORLDWIDE LLC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.) 138
13.2.1 COMPANY SNAPSHOT 138
13.2.2 COMPANY SHARE ANALYSIS 138
13.2.3 PRODUCT PORTFOLIO 139
13.2.4 RECENT DEVELOPMENT 139
13.3 SHANGHAI FOSUN PHARMACUETICAL (GROUP) CO,LTD 140
13.3.1 COMPANY SNAPSHOT 140
13.3.2 REVENUE ANALYSIS 140
13.3.3 COMPANY SHARE ANALYSIS 141
13.3.4 PRODUCT PORTFOLIO 141
13.3.5 RECENT DEVELOPMENT 141
13.4 BAUSCH HEALTH COMPANIES INC. 142
13.4.1 COMPANY SNAPSHOT 142
13.4.2 REVENUE ANALYSIS 142
13.4.3 COMPANY SHARE ANALYSIS 143
13.4.4 PRODUCT PORTFOLIO 143
13.4.5 RECENT DEVELOPMENT 143
13.5 CANDELA MEDICAL 144
13.5.1 COMPANY SNAPSHOT 144
13.5.2 COMPANY SHARE ANALYSIS 144
13.5.3 PRODUCT PORTFOLIO 145
13.5.4 RECENT DEVELOPMENT 145
13.6 CUTERA 146
13.6.1 COMPANY SNAPSHOT 146
13.6.2 REVENUE ANALYSIS 146
13.6.3 PRODUCT PORTFOLIO 147
13.6.4 RECENT DEVELOPMENTS 147
13.7 CYNOSURE (A SUBSIDIARY OF HOLOGIC INC.) 148
13.7.1 COMPANY SNAPSHOT 148
13.7.2 PRODUCT PORTFOLIO 148
13.7.3 RECENT DEVELOPMENT 149

13.8 LUTRONIC INC. 150
13.8.1 COMPANY SNAPSHOT 150
13.8.2 PRODUCT PORTFOLIO 150
13.8.3 RECENT DEVELOPMENTS 151
13.9 AEROLASE CORP. 152
13.9.1 COMPANY SNAPSHOT 152
13.9.2 PRODUCT PORTFOLIO 152
13.9.3 RECENT DEVELOPMENTS 152
13.10 AIRXPANDERS, INC. 153
13.10.1 COMPANY SNAPSHOT 153
13.10.2 PRODUCT PORTFOLIO 153
13.10.3 RECENT DEVELOPMENT 153
13.11 BTL. 154
13.11.1 COMPANY SNAPSHOT 154
13.11.2 PRODUCT PORTFOLIO 154
13.11.3 RECENT DEVELOPMENT 154
13.12 GC AESTHETICS 155
13.12.1 COMPANY SNAPSHOT 155
13.12.2 PRODUCT PORTFOLIO 155
13.12.3 RECENT DEVELOPMENT 156
13.13 LUMENIS 157
13.13.1 COMPANY SNAPSHOT 157
13.13.2 PRODUCT PORTFOLIO 157
13.13.3 RECENT DEVELOPMENT 157
13.14 MEDYTROX 158
13.14.1 COMPANY SNAPSHOT 158
13.14.2 PRODUCT PORTFOLIO 158
13.14.3 RECENT DEVELOPMENT 158
13.15 MERZ NORTH AMERICA, INC. 159
13.15.1 COMPANY SNAPSHOT 159
13.15.2 PRODUCT PORTFOLIO 159
13.15.3 RECENT DEVELOPMENTS 160
13.16 QUANTA SYSTEM 161
13.16.1 COMPANY SNAPSHOT 161
13.16.2 PRODUCT PORTFOLIO 161
13.16.3 RECENT DEVELOPMENT 161
13.17 SHARPLIGHT TECHNOLOGIES LLC 162
13.17.1 COMPANY SNAPSHOT 162
13.17.2 PRODUCT PORTFOLIO 162
13.17.3 RECENT DEVELOPMENT 163
13.18 SIENTRA, INC. 164
13.18.1 COMPANY SNAPSHOT 164
13.18.2 REVENUE ANALYSIS 164
13.18.3 PRODUCT PORTFOLIO 165
13.18.4 RECENT DEVELOPMENT 165
13.19 SUNEVA MEDICAL 166
13.19.1 COMPANY SNAPSHOT 166
13.19.2 PRODUCT PORTFOLIO 166
13.19.3 RECENT DEVELOPMENT 166
13.20 VENUS CONCEPT 167
13.20.1 COMPANY SNAPSHOT 167
13.20.2 REVENUE ANALYSIS 167
13.20.3 PRODUCT PORTFOLIO 168
13.20.4 RECENT DEVELOPMENTS 168
14 QUESTIONNAIRE 169
15 RELATED REPORTS 172